Interest in BRCA1/2 testing in a primary care population

Preventive Medicine

Volumn 34, Issue 6, 2002, Pages 590-595

  Armstrong, Katrina ^a   Weber, Barbara ^a   Ubel, Peter A ^a   Guerra, Carmen ^a   Schwartz, J Sanford ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

EID: 0036353167     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2002.1022     Document Type: Article

References (48)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
4. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
5. Breast and ovarian cancer incidence in BRCA1 mutation carriers
6. Relationship between medical genetics and public health: Changing the paradigm of disease prevention and the definition of a genetic disease
7. Estimate of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
8. Physicians' knowledge of genetics and genetic tests
9. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
10. Are we ready to screen for inherited susceptibility to cancer?
11. Genetic counseling for families with inherited susceptibility to breast and ovarian cancers
12. Genetic testing for cancer susceptibility
13. Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition
14. Statement on use of DNA testing for presymptomatic identification of cancer risk
15. Position paper: Hereditary susceptibility testing for breast cancer
16. Breaking ranks, lab offers test to assess risk of breast cancer
17. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
18. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
19. DNA chips survey an entire genome
20. Informed decision making in outpatient practice: Time to get back to basic
21. How doctors and patients discuss routine clinical decisions. Informed decision making in the outpatient setting
22. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
23. Sequence analysis of BRCA1 and BRCA1: Correlations of mutations with family history and ovarian cancer risk
24. Hereditary cancer risk notification and testing: How interested is the general population?
25. Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population
26. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families
27. Interest in genetic testing among first-degree relatives of breast cancer patients
28. Attitudes about genetic testing for breast-ovarian cancer susceptibility
29. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families
30. Women's receptivity to testing for a genetic susceptibility to breast cancer
31. BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes
32. A study of the relationship between family history of breast cancer and knowledge of breast cancer genetic testing prerequisites
33. Fear arousing communications
34. Psychological distress and surveillance behaviors of women with a family history of cancer
35. Risk perception, family history and use of breast cancer screening tests
36. Factors associated with repeat adherence to breast cancer screening
37. The risk factors of age and family history and their relationship to screening mammography utilization
38. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk
39. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing
40. Ethnic differences in risk perception among women at increased risk for breast cancer
41. Use of mammography - United States, 1990
42. Use of health services by African-American children with asthma on Medicaid
43. The effects of race on use of physician services
44. The theory of reasoned action: A meta-analysis of past research with recommendation for modifications and future research
45. Informed consent and BRCA1 testing